Skipping standard axillary lymph node dissection led to very low rates of axillary recurrence in patients with node-positive breast cancer who became node-negative following neoadjuvant chemotherapy, ...

Patients with breast cancer may be able to avoid lymphedema, which can occur after surgery to remove lymph nodes in the ...

Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...

MIAMI BEACH -- The surgical dogma favoring axillary dissection in breast cancer continues to give way to more selective data-driven strategies that allow more women to avoid axillary surgery, an ...

Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements Nine hundred thirty-six women who underwent SLN biopsy ...

Please provide your email address to receive an email when new articles are posted on . Hispanic, Black and Asian women experience more subjective arm swelling compared with white women after axillary ...

The word “dissection” may conjure images of a high school biology lab full of frogs or sheep’s eyeballs in various stages of deconstruction. But an axillary node dissection is a decidedly different ...

Locoregional recurrence rate of 2.9% overall with no variation across node-defined risk gr ...

Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: A systematic review and meta-analysis. This ...

Ten-year findings suggest some patients may safely receive less treatment, potentially lowering side effects without raising ...

Future breast cancer treatment options may not only increase patients’ survival but also reduce or eliminate their need for surgery altogether, says breast cancer surgeon Sara Javid, MD, Fred ...

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no detrimental effect on outcomes in most cases, continuing a trend toward less ...